Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The approvals in June of two gene therapies, Elevidys and ...
Cell and gene therapy has evolved into one of the biopharma industry's hottest markets, with a major splash of investment and a run of approvals anticipated in the coming years. To meet what's likely ...
In 2018, Japanese multinational conglomerate Fujifilm up and decided it wanted to become a major player in supplying cell and gene therapy manufacturing, so it purchased two key companies—one in the U ...
FREDERICK, Maryland (Reuters) - Gilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. biotech's manufacturing processes, an ...
LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems today announced that Huntsman Cancer Institute at the University of Utah has signed a contract for a second MEVION S250i Proton Therapy System ...
Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "U.S. Cell and Gene Therapy CDMO Market Size, Share & Trends Analysis Report by Phase (Pre-clinical, Clinical), Product (Gene Therapy, Cell Therapy, ...
Some of the newest and most exciting gene therapy technologies share a problem: They’re too bulky. They rely on multiple functional DNA and protein elements that must reach target cells all at the ...
A recent study led by Dr Assumpció Bosch demonstrates the potential of gene therapy to restore motor capacity in an ultra-rare disease, Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results